Oncogenic and tumor suppressive roles of polo‐like kinases in human hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Hepatology

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.23467PMID 20112253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

  2009cited by this paper
• A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53

  2009cited by this paper
• Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC

  2009cited by this paper
• Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma

  2009cited by this paper
• Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression

  2008cited by this paper
• p73-mediated transcriptional activity is negatively regulated by Polo-like kinase 1

  2008cited by this paper
• Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions.

  2008cited by this paper
• Molecular targeted therapies in hepatocellular carcinoma

  2008cited by this paper
• The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint.

  2008cited by this paper
• Inhibitory Role of Plk1 in the Regulation of p73-dependent Apoptosis through Physical Interaction and Phosphorylation*

  2008cited by this paper
• Aberrant Polo-Like Kinase 1-Cdc25A Pathway in Metastatic Hepatocellular Carcinoma

  2008cited by this paper
• Polo-like kinase 3 is required for entry into S phase

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Hepatocellular carcinoma pathogenesis: from genes to environment

  2006cited by this paper
• Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies.

  2006cited by this paper
• Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

  2006cited by this paper
• Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis

  2005cited by this paper
• The Polo kinase Plk4 functions in centriole duplication

  2005cited by this paper
• Structure and function of Polo-like kinases

  2005cited by this paper
• Sak/Plk4 and mitotic fidelity

  2005cited by this paper
• Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues

  2005cited by this paper
• Polo-like kinases and oncogenesis

  2005cited by this paper
• Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

  2004cited by this paper
• Polo-like kinases and the orchestration of cell division

  2004cited by this paper
• Polo-like kinase-2 is required for centriole duplication in mammalian cells.

  2004cited by this paper
• Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.

  2004cited by this paper
• The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis.

  2004cited by this paper
• Polo-like kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle.

  2004cited by this paper
• Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation*

  2004cited by this paper
• Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

  2003cited by this paper
• Molecular pathogenesis of human hepatocellular carcinoma

  2002cited by this paper
• Cell Cycle Arrest and Apoptosis Induced by Human Polo-Like Kinase 3 Is Mediated through Perturbation of Microtubule Integrity

  2002cited by this paper
• MethPrimer: designing primers for methylation PCRs

  2002cited by this paper
• Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways

  2002cited by this paper
• Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells

  2002cited by this paper
• Late mitotic failure in mice lacking Sak, a polo-like kinase.

  2001cited by this paper
• Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma

  1999cited by this paper
• Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas.

  1999cited by this paper
• Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progression.

  1998cited by this paper
• Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase.

  1997cited by this paper
• Simplified mammalian DNA isolation procedure.

  1991cited by this paper

• Abnormal PLK2 expression is associated with specific subtypes and may help risk stratification in acute myeloid leukemia

  2026cites this paper
• BAG6 promotes hepatocellular carcinoma growth via enhancing PLK1-mediated aerobic glycolysis.

  2025cites this paper
• Comprehensive analysis reveals PLK3 as a promising immune target and prognostic indicator in glioma

  2025cites this paper
• Polo-like kinase 4: A molecular linchpin in cancer and its management

  2025cites this paper
• Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer

  2025cites this paper
• Diosgenin potentiates the anticancer effect of doxorubicin and volasertib via regulating polo-like kinase 1 and triggering apoptosis in hepatocellular carcinoma cells

  2024cites this paper
• Therapeutic potential of targeting polo-like kinase 4.

  2024cites this paper
• STEAP4 with copper reductase activity suppresses tumorigenesis by regulating the cell cycle in hepatocellular carcinoma cells

  2024cites this paper
• High PLK3 levels are linked with less tumor invasion, lower FIGO stage and better prognosis of endometrial cancer.

  2024cites this paper
• Integrated transcriptomic and metabolomic analysis of the hepatotoxicity of dichloroacetonitrile.

  2024cites this paper
• Plk3 Enhances Cisplatin Sensitivity of Nonsmall-Cell Lung Cancer Cells through Inhibition of the PI3K/AKT Pathway via Stabilizing PTEN

  2024cites this paper
• Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario

  2023cites this paper
• Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis

  2023cites this paper
• Polo-like kinase-1 mediates hepatitis C virus-induced cell migration, a drug target for liver cancer

  2023cites this paper
• DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells

  2023cites this paper
• Cell cycle kinases (AUKA, CDK1, PLK1) are prognostic biomarkers and correlated with tumor-infiltrating leukocytes in HBV related HCC

  2023cites this paper
• SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis

  2022cites this paper
• Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma

  2022cites this paper
• PLK2 Single Nucleotide Variant in Gastric Cancer Patients Affects miR-23b-5p Binding

  2022cites this paper
• PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC

  2022cites this paper
• Plk2-mediated phosphorylation and translocalization of Nrf2 activates anti-inflammation through p53/Plk2/p21cip1 signaling in acute kidney injury

  2022cites this paper
• Polo-Like Kinase 2: From Principle to Practice

  2022cites this paper
• Therapeutic Potential of Mitotic Kinases’ Inhibitors in Cancers of the Gastrointestinal System

  2022cites this paper
• LINC00152 Drives a Competing Endogenous RNA Network in Human Hepatocellular Carcinoma

  2022cites this paper
• p53 protects against genome instability following centriole p53 protects against genome instability following centriole duplication failure duplication failure us know how access to this document benefits you.

  2022cites this paper
• Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma

  2022cites this paper
• Keep Calm and Carry on with Extra Centrosomes

  2022cites this paper
• STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway

  2021cites this paper
• Comprehensive Analysis Reveals Promising Immune Target and Prognostic Value of PLK3 in Glioma

  2021cites this paper
• Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer.

  2021cites this paper
• Review of: "Timing of transcriptomic peripheral blood mononuclear cell responses of sheep to Fasciola hepatica infection differs from those of cattle, reflecting different disease phenotypes"

  2021cites this paper
• TEC kinase stabilizes PLK4 to promote liver cancer metastasis.

  2021cites this paper
• Down‐regulation of Polo‐like kinase 4 (PLK4) induces G1 arrest via activation of the p38/p53/p21 signaling pathway in bladder cancer

  2021cites this paper
• Timing of Transcriptomic Peripheral Blood Mononuclear Cell Responses of Sheep to Fasciola hepatica Infection Differs From Those of Cattle, Reflecting Different Disease Phenotypes

  2021cites this paper
• High SGO2 Expression Predicts Poor Overall Survival: A Potential Therapeutic Target for Hepatocellular Carcinoma

  2021cites this paper
• Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics

  2021cites this paper
• Investigating the Functions of PLK4 in Epigenetic Regulation

  2021cites this paper
• Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer

  2021cites this paper
• MoS2-based nanocomposites for cancer diagnosis and therapy

  2021cites this paper
• Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy

  2021cites this paper
• Knocking down of Polo-like kinase 2 inhibits cell proliferation and induced cell apoptosis in human glioma cells.

  2021cites this paper
• Serum Response Factor (SRF) Drives the Transcriptional Upregulation of the MDM4 Oncogene in HCC

  2021cites this paper
• Alternative Splicing in Hepatocellular Carcinoma

  2020cites this paper
• Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells

  2020cites this paper
• STK 39 is a novel kinase contributing to the progression of hepatocellular 1 carcinoma by the PLK 1 / ERK signaling pathway 2

  2020cites this paper
• DNA methylation of tumor suppressor genes in hepatocellular carcinoma

  2020cites this paper
• Non-mitotic functions of polo-like kinases in cancer cells.

  2020cites this paper
• Inhibiting IRE1α-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma

  2020cites this paper
• Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx

  2020cites this paper
• Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.

  2020cites this paper
• Novel molecular targets in hepatocellular carcinoma

  2020cites this paper
• Novel biomarker for hepatocellular carcinoma: high tumoral PLK-4 expression is associated with better prognosis in patients without microvascular invasion.

  2020cites this paper
• Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer

  2020cites this paper
• PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma

  2020cites this paper
• Recent advances in liver transplantation for cancer: The future of transplant oncology

  2019cites this paper
• PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.

  2019cites this paper
• Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells in Vitro and in Vivo.

  2019cites this paper
• Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer

  2019cites this paper
• Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2

  2019cites this paper
• Upregulation of microRNA‐27a inhibits synovial angiogenesis and chondrocyte apoptosis in knee osteoarthritis rats through the inhibition of PLK2

  2019cites this paper
• Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy

  2019cites this paper
• Comprehensive analysis of long non-coding RNA-messenger RNA-microRNA co-expression network identifies cell cycle-related lncRNA in hepatocellular carcinoma

  2019cites this paper
• PLK4: a promising target for cancer therapy

  2019cites this paper
• Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression

  2019cites this paper
• Blocking IRE1a;-endoribonuclease activity in hepatic stellate cells decreases tumor cell proliferation and metastasis in hepatocellular carcinoma

  2019cites this paper
• Splicing Regulator p54nrb/Non–POU Domain–Containing Octamer‐Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box–Dependent Interacting Protein 1 in Hepatocellular Carcinoma

  2019cites this paper
• Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer.

  2018cites this paper
• Coupling function of cyclin‐dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma

  2018cites this paper
• MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway

  2018cites this paper
• Haplotype-resolved and integrated genome analysis of ENCODE cell line HepG2

  2018cites this paper
• Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2

  2018cites this paper
• PLK4: a link between centriole biogenesis and cancer

  2018cites this paper
• High PLK4 expression promotes tumor progression and induces epithelial-mesenchymal transition by regulating the Wnt/β-catenin signaling pathway in colorectal cancer

  2018cites this paper
• Sensitivity of TP53‐Mutated Cancer Cells to the Phytoestrogen Genistein Is Associated With Direct Inhibition of Plk1 Activity

  2017cites this paper
• The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis

  2017cites this paper
• Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells.

  2017cites this paper
• Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.

  2017cites this paper
• Microenvironment Signals and Mechanisms in the Regulation of Osteosarcoma

  2017cites this paper
• Polo-Like Kinase 4 (PLK4) Function in Cancer Progression

  2017cites this paper
• PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis

  2017cites this paper
• 7 Centrosome Abnormality and Human Lung Cancer

  2017cites this paper
• CHOP negatively regulates Polo-like kinase 2 expression via recruiting C/EBPα to the upstream-promoter in human osteosarcoma cell line during ER stress.

  2017cites this paper
• iTRAQ-Based Quantitative Proteomic Analysis of the Inhibitory Effects of Polysaccharides from Viscum coloratum (Kom.) Nakai on HepG2 Cells

  2017cites this paper
• 7-6-2015 p 53 protects against genome instability following centriole duplication failure

  2017cites this paper
• Human male infertility and its genetic causes

  2017cites this paper
• Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

  2016cites this paper
• Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.

  2016cites this paper
• Dendrosome mediated topical gene silencing by PLK-1 specific siRNA: implication in treatment of skin cancer in mouse model

  2016cites this paper
• The role of Plk3 in oncogenesis

  2016cites this paper
• Response of the hepatic transcriptome to aflatoxin B1 in ducklings.

  2016cites this paper
• A PLK4 mutation causing azoospermia in a man with Sertoli cell‐only syndrome

  2016cites this paper
• PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma

  2016cites this paper
• Cytoskeletal architecture and cell motility remain unperturbed in mouse embryonic fibroblasts from Plk3 knockout mice

  2016cites this paper
• HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100

  2016cites this paper
• Long noncoding RNA lnc-RI is a new regulator of mitosis via targeting miRNA-210-3p to release PLK1 mRNA activity

  2016cites this paper
• Polo-like kinase 3 and phosphoT273 caspase-8 are associated with improved local tumor control and survival in patients with anal carcinoma treated with concomitant chemoradiotherapy

  2016cites this paper
• PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors.

  2016cites this paper
• Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor

  2016cites this paper
• Checkpoint mitótico como alvo terapêutico para sensibilizar células cancerígenas a agentes antimitóticos

  2015cites this paper
• Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.

  2015cites this paper